Friday, October 18, 2019 (HealthDay News)-There are significant racial disparities in the treatment of patients in the United States Multiple myeloma, New research shows.
The researchers reviewed national data on 3,504 whites, 858 blacks, and 468 Hispanic patients treated between 2007 and 2013.
Average time between multiple Myeloma Caucasian diagnosis and treatment initiation was 2.7 months. 4.6 months for Hispanics. 5.2 months for blacks.
Drug Usually the first course of treatment for this type of blood cancer.. When treatment is delayed, patients suffer from organ damage, kidney problems, anemia, Fractures, infections and other serious health problems.
Dr. Sikander Ailawadhi, an oncologist and lead author at the Mayo Clinic in Jacksonville, Florida, said:
During the study period, the probability of starting treatment within 6 months of diagnosis increased in three groups. However, whites and Hispanics improved more than blacks.
Autologous stem cell transplantation is considered the standard treatment for eligible patients. Transplantation rates within one year of diagnosis increased between whites and blacks, but not among Hispanics.
Median overall survival was similar for all three groups. (The median means that half survived longer and half lived shorter.) However, the authors compare with previous studies that blacks are treated equally and in a timely manner. Hopefully, blacks could have had a better survival rate, he said.
“Since our analysis is based on Medicare patient data, these disparities are not due to differences in insurance coverage. Even in this seemingly equal access environment, patients are treated equally. Not, “Ailawadhi said in a news release from the American Society of Hematology.
Researchers have also found that medical costs are the highest of any Hispanic. Their average monthly medical bill was $ 12,657, while blacks were $ 11,546 and whites were $ 10,143.
The authors stated that the high amount of Hispanics may be due in part to the high cost of hospitalization, probably due to complications due to delays in treatment.
Ailawadhi said further research is needed to investigate the underlying reasons for racial inequality.
“We hope that understanding and dealing with them will lead to a more equitable medical access, cost, and outcome profile for all. Multiple myeloma Patients, regardless of race or ethnicity. “
This study was published in the journal on October 17th. Blood Advance..
Copyright © 2019 Health Day. all rights reserved.
sauce: Blood Advance, News Release, October 17, 2019
Studies Reveal Racial Gap in Treatment of Multiple Myeloma
Source link Studies Reveal Racial Gap in Treatment of Multiple Myeloma